Johnson & Johnson Stock: Quality, Doesn't Deserve A Mid-20s Multiple Right Now (NYSE:JNJ)
· seekingalpha.com
JNJ stock is up 28% YTD, beating SPY/XLV, but a premium valuation may cap upside.
Johnson & Johnson ( JNJ ) continues to have a great year, flying under the radar amid the AI boom. Shares are up 28% total return so far in 2026, sharply outper...